WINTON GROUP Ltd Purchases New Shares in GE HealthCare Technologies Inc. $GEHC

WINTON GROUP Ltd acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 178,600 shares of the company’s stock, valued at approximately $11,432,000.

Other hedge funds have also recently bought and sold shares of the company. California State Teachers Retirement System grew its stake in shares of GE HealthCare Technologies by 5,693.1% in the 2nd quarter. California State Teachers Retirement System now owns 40,913,912 shares of the company’s stock worth $2,618,900,000 after acquiring an additional 40,207,660 shares in the last quarter. Auto Owners Insurance Co lifted its position in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Norges Bank purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $533,655,000. Finally, Cynosure Group LLC grew its position in GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after purchasing an additional 4,344,817 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 2.4%

GE HealthCare Technologies stock opened at $65.17 on Thursday. The firm has a 50 day moving average price of $68.43 and a 200-day moving average price of $68.60. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a market capitalization of $29.44 billion, a P/E ratio of 14.95, a P/E/G ratio of 1.76 and a beta of 0.70.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The company had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the previous year, the firm posted $1.06 EPS. GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were paid a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.21%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of GE HealthCare Technologies in a research note on Wednesday, August 12th. BTIG Research reaffirmed a “buy” rating and issued a $79.00 target price on shares of GE HealthCare Technologies in a report on Wednesday, August 19th. BMO Capital Markets began coverage on GE HealthCare Technologies in a research report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price target for the company. Oppenheimer reiterated an “outperform” rating on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Finally, Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, July 30th. Ten equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics and digital solutions company headquartered in Chicago, Illinois. The company provides products and services designed to support healthcare providers across diagnostic imaging, clinical care and treatment planning.

Its portfolio includes imaging systems such as magnetic resonance imaging, computed tomography, molecular imaging, X-ray and surgical imaging equipment. GE HealthCare also offers ultrasound systems, patient monitoring and care solutions, anesthesia delivery and respiratory care products, maternal and infant care technologies, and healthcare information technology.

The company’s Pharmaceutical Diagnostics business develops and supplies contrast media and radiopharmaceuticals used to enhance medical imaging and support the detection and monitoring of disease.